SARS-CoV-2 (2 Challenges) EQA/PT Scheme

To assess the proficiency of laboratories in the detection of SARS-CoV-2 coronavirus.

To assess the proficiency of laboratories in the differentiation of different coronavirus genotypes.

Total Number of Challenges: 2
Number of Panel Members: 5
Distribution / Testing Period: Q2 & Q4
Sample NA Target Source Cultured and/or Clinical material
Matrix Panel Format Transport Medium
Panel Member Target Range Covering clinical range
Panel Member Sample Volume 1.0 ml
Panel Sample Pre-treatment Requirement Ready for analysis. Treat as clinical samples and analyse accordingly.
Panel Analysis Type Qualitative
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions <-20°C / Frozen on Dry-ice
Accreditation / Regulatory Status Accredited to ISO 17043

$1,586.71